HODGKIN LYMPHOMA DRUG MARKET SCENARIO
Data Bridge Market Research analyses that the Hodgkin lymphoma drug will exhibit a CAGR of around 14.75% for the forecast period of 2022-2029. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, Hodgkin lymphoma in pediatric populations worldwide...